Aerie Pharmaceuticals Profile

USD 0.75  1.25%
57.4Last Month High 64.9 
59.01Trading Day  High 60.6 

Sale by Acp Iv Lp of 300000 shares of Aerie Pharmaceuticals

Aerie Pharmaceuticals Inc insider trading alert for sale of common stock by Acp Iv Lp, the corporate stakeholder, on September 25, 2017. This event was filed by Aerie Pharmaceuticals Inc with SEC on 2014-05-27. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Aerie Pharmaceuticals Summary

Aerie Pharmaceuticals Inc (AERI) is traded on NASDAQ General Markets in USA. It is located in NORTH CAROLINA, U.S.A and employs 70 people. Aerie Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.2 B. Aerie Pharmaceuticals Inc has 36.7 M outstanding shares of which 3.97 M shares are presently shorted by private and institutional investors with about 8.81 trading days to cover. Aerie Pharmaceuti currently holds about 281.33 M in cash with (85.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.66.
Check Aerie Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Aerie Pharmaceuticals Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Aerie Pharmaceuticals Against Markets

Current Ratings  

Aerie Pharmaceuticals 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 5% 
Aerie Pharmaceuticals, Inc., a clinicalstage pharmaceutical company, focuses on the discovery, development, and commercialization of firstinclass therapies for the treatment of glaucoma and other eye diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAerie Pharmaceuticals Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
Business Address2030 Main Street Suite 1500, Irvine, CA 92614, United States
ExchangeNASDAQ General Markets
CIK Number01337553.0
IndustryPharmaceutical Products
Contact Number949 526 8700
CurrencyUSD - US Dollar


Aerie Pharmaceuticals Analyst Recommendations
Target PriceAdvice# of Analysts
Aerie Pharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Aerie Pharmaceuticals Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Aerie Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.66March 7, 2017
Aerie Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate